Effectiveness and safety of the available preventive tuberculosis treatment regimens for children and adolescents: systematic review and network meta-analysis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy and Safety of Current Preventive Treatment Options for Tuberculosis in Pediatric Populations: A Systematic Review and Network Meta-Analysis

  • By

  • Vanessa Sabella-Jiménez

  • Dione Benjumea-Bedoya

  • Yenifer Hoyos-Mendez

  • Andrés Felipe Estupiñán-Bohorquez

  • Jorge Acosta-Reyes

  • Ivan D Florez

  • September 30, 2026

Share

Clinical Report: Efficacy and Safety of Current Preventive Treatment Options for Tuberculosis in Pediatric Populations

Overview

This systematic review and network meta-analysis evaluated the efficacy and safety of tuberculosis preventive treatment regimens in children.

Background

Children are at a higher risk of progressing from tuberculosis infection to active disease compared to adults, yet research has predominantly focused on adult populations. Effective preventive treatment strategies are crucial to mitigate this risk.

Data Highlights

RegimenActive TB Cases (RR)Adherence (RR)Adverse Reactions (OR)
4HR vs 9H0.49 (95% CI 0.32 to 0.76)1.07 (95% CI 1.01 to 1.14)-
3HP vs 9H-1.09 (95% CI 1.03 to 1.15)4.56 (95% CI 1.22 to 16.96)
4R vs 9H-1.12 (95% CI 1.05 to 1.20)0.34 (95% CI 0.20 to 0.58)

Key Findings

  • 4 months of isoniazid and rifampicin (4HR) was associated with fewer active TB cases compared to 9 months of isoniazid (9H).
  • Treatment adherence was higher with isoniazid + rifapentine for 3 months (3HP), 4HR, and rifampicin for 4 months (4R) compared to 9H.
  • Adverse reactions were more likely with 3HP than with 4HR or 4R.
  • Adverse reactions occurred less frequently with 4R than with 9H.

Clinical Implications

The findings suggest that short-course regimens, such as 3HP and 4HR, may be preferable for pediatric patients due to better adherence and lower incidence of active TB. Clinicians should consider these options when developing treatment plans for children at risk of tuberculosis.

Conclusion

This systematic review highlights the potential advantages of short-course preventive treatment regimens for tuberculosis in children.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Frontiers in Medicine — The role of digital health interventions for adults with tuberculosis: a network meta-analysis of randomized controlled trials
  3. Open Forum Infectious Diseases — Enhanced Management Strategies for Tuberculous Meningitis in Adults: A Comprehensive Review and Meta-analysis
  4. The Journal of Infectious Diseases — Calculating Levofloxacin Dosages for Preventive Treatment of Tuberculosis in Youth Exposed to Rifampicin-Resistant Strains
  5. Open Forum Infectious Diseases — Predictors of Early Termination of Preventive Therapy in Children Exposed to Multidrug-Resistant Tuberculosis in Household Settings
  6. The role of digital health interventions for adults with tuberculosis: a network meta-analysis of randomized controlled trials
  7. Enhanced Management Strategies for Tuberculous Meningitis in Adults: A Comprehensive Review and Meta-analysis
  8. Calculating Levofloxacin Dosages for Preventive Treatment of Tuberculosis in Youth Exposed to Rifampicin-Resistant Strains
  9. Executive summary - WHO consolidated guidelines on tuberculosis - NCBI Bookshelf
  10. Three Months of Weekly Rifapentine and Isoniazid Versus Four Months of Daily Rifampicin for Tuberculosis Infection: A Randomized Controlled Trial | Clinical Infectious Diseases | Oxford Academic

Original Source(s)

Related Content